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Background: Coxiella burnetii is a highly clonal microorganism which is difficult to culture, requiring BSL3 conditions for
its propagation. This leads to a scarce availability of isolates worldwide. On the other hand, published methods of
characterization have delineated up to 8 different genomic groups and 36 genotypes. However, all these methodologies,
with the exception of one that exhibited limited discriminatory power (3 genotypes), rely on performing between 10 and
20 PCR amplifications or sequencing long fragments of DNA, which make their direct application to clinical samples
impracticable and leads to a scarce accessibility of data on the circulation of C. burnetii genotypes.
Results: To assess the variability of this organism in Spain, we have developed a novel method that consists of a
multiplex (8 targets) PCR and hybridization with specific probes that reproduce the previous classification of this organism
into 8 genomic groups, and up to 16 genotypes. It allows for a direct characterization from clinical and environmental
samples in a single run, which will help in the study of the different genotypes circulating in wild and domestic cycles as
well as from sporadic human cases and outbreaks. The method has been validated with reference isolates. A high
variability of C. burnetii has been found in Spain among 90 samples tested, detecting 10 different genotypes, being those
adaA negative associated with acute Q fever cases presenting as fever of intermediate duration with liver involvement
and with chronic cases. Genotypes infecting humans are also found in sheep, goats, rats, wild boar and ticks, and the only
genotype found in cattle has never been found among our clinical samples.
Conclusions: This newly developed methodology has permitted to demonstrate that C. burnetii is highly variable in
Spain. With the data presented here, cattle seem not to participate in the transmission of C. burnetii to humans in the
samples studied, while sheep, goats, wild boar, rats and ticks share genotypes with the human population.Background
Coxiella burnetii is an obligate intracellular Gram nega-
tive bacterium which causes Q fever, an illness with mul-
tiple clinical manifestations in its acute presentation,
including a flu-like respiratory process that could result in
atypical pneumonia, or fever of intermediate duration (FID)
with liver involvement. In a low percentage of cases a
chronic form of the disease is diagnosed, characterized by* Correspondence: ijado@isciii.es
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reproduction in any medium, provided the oran infection that persists for more than 6 months, more fre-
quently endocarditis, which can be fatal without an appro-
priate treatment [1]. Its high infectivity, resistance in
adverse environmental conditions and aerosol route of
transmission make this agent a candidate for intentional re-
lease [2], being listed as a category B bioterrorism agent by
the USA Centers for Disease Control and Prevention.
Initial studies tried to correlate specific genotypes (GT)
with the chronic and acute forms of the disease. Thus,
certain plasmid patterns were claimed to be associated
with the disease outcome [3,4], which was controversial
[5]; also, some isocitrate dehydrogenase types were asso-
ciated with chronic disease and a role for this gene in thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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was proposed [6], although this association was also chal-
lenged by other authors [7].
More recently, different attempts have been made to
classify isolates of C. burnetii in different genomic
groups (GG). Based on restriction fragment length poly-
morphism (RFLP) of the entire genome, Hendrix et al.
[8] resolved 36 isolates of different origin in 6 GG; Jager
et al. [9] performed pulsed field gel electrophoresis
(PFGE) in 80 isolates that were classified into 4 GG; a
Multispacer Sequence Typing method [10], based on the
sequencing of 10 intergenic spacers classified 173 iso-
lates, mainly from chronic disease, into 3 monophyletic
groups and 30 GT; later, a reduced MST method was
published by Mediannikov et al. [11], targeting 3 spacers
in a single PCR, detecting 3 MST GTs; Svraka et al. [12]
amplified different variable number tandem repeats
(VNTR) in 7 PCR protocols, describing 5 clusters and
validating previous GG ascriptions; Arricau-Bouvery [13]
applied infrequent restriction site-PCR and multilocus
variable number of tandem repeats analysis (MLVA) for
the typing in a scheme of 17 PCR protocols leading to a
classification into 6 clusters and 36 GT; later, Roest et al.
[14], used the same method but reducing the 17
described targets to 10, to study an outbreak in the
Netherlands and describing 13 MLVA types; Beare et al.
[15] added two more GG, totalling up to 8, in a
microarray-based whole genome comparison; Denison
et al. [16] performed 20 PCRs for the characterization of the
region within and near the transposase IS1111, describing 5
GG among 21 reference strains and 9 animal samples;
Huijsmans et al. [17] developed a method for a single-
nucleotide-polymorphisms (SNP)-based typing, applying 10
real time PCR protocols that resolved 28 reference strains
and 40 samples from an outbreak into 9 SNP genotypes,
while a previous study on the same 28 reference strains [13]
had disclosed 14 MLVA types; finally, Hornstra et al. [18]
performed 14 SNP-based real time PCR assays that classified
63 isolates into 6 GG and 35 MSTgenotypes.
Recently, an outer membrane protein-coding gene
named acute disease antigen A (adaA) was described as
associated with acute Q fever-causing strains, whereas
adaA negative strains were linked to chronic cases [19].
Therefore, the hypothesis of its association with a specific
clinical presentation of the disease together with its
immunodominant nature lead the authors to suggest that
adaA may be a virulence factor for the pathogenesis of Q
fever. Consequently, adaA may be a relevant genetic mar-
ker for differentiation among isolates.
In general, there has been a good correlation between
typing methods although with different discriminatory
capabilities. However, although 2 previous descriptions
have been applied directly to clinical samples [16,17], both
rely on the amplification of several targets performingbetween 10 and 20 PCR protocols, which make it not al-
ways feasible for their use in a clinical setting due to the
frequent scarcity of testable sample-size, which hampers
the acquisition of global data; the method of Mediannikov
et al. [11], consisting of a multiplex PCR targeting 3 inter-
genic spacers, exhibited however a limited discriminatory
power (3 MST types) in the samples studied. In this study,
based on the previous descriptions of Beare et al. [15] and
Zhang et al. [19], a fast, reproducible and sensitive multi-
plex PCR that amplifies 8 targets in the same run for a
rapid GT determination, has been developed to be applied
to both isolates and PCR-positive samples. With this
method, C. burnetii could be classified into 8 GG and up
to 16 GT. Based on this methodology, a comprehensive
study on the variability of C. burnetii in Spain have been
made with samples from patients with acute and chronic
Q fever, domestic and wild mammals and ticks, demon-
strating a high variability of this organism and an associ-
ation between genotypes and human disease.
Methods
Samples
Fifteen C. burnetii reference isolates were used to validate
the typing method (Additional file 1: Table S1). Also,
human and animal samples (livestock, wild animals and
ticks) sent to the National Reference Laboratory at the
Instituto de Salud Carlos III and to the clinical and
veterinarian collaborating laboratories for diagnosis of Q
fever were included in the study, including defibrinated
blood, plasma, biopsy material, ruminant placentas, mostly
from abortions with the exception of 3 cattle placentas
from normal parturitions (Additional file 1: Table S1), and
other tissues from domestic and wild animals, and
questing ticks, that were collected from different areas in
Central Spain: 4 areas in Madrid (Cercedilla, Aranjuez,
Perales and Valdeolmos) and 1 in Toledo (Oropesa). In all
the areas the presence of livestock was documented (cattle
in all areas and sheep and swine only in Oropesa). There
were remarkable high densities of rabbits (Oryctolagus
cuniculus) in all the areas except Cercedilla. The study
protocol was approved by the Bioethics and Animal
Welfare Committee of the Instituto de Salud Carlos III,
Spain (ref. CBBA/4 2006), where the study was conducted,
respecting individual privacy according to relevant data
protection legislation and animal welfare. Also, human
clinical samples used in the study were made available to
us in an anonymized manner.
Culture
Standard shell-vial methodology was used as previously
described [20] to grow C. burnetii in Vero E6 cells
(European Collection of Cell Cultures; provided by
Sigma-Aldrich Química S.A., Tres Cantos, Madrid,
Spain). All the propagative methods and those related to
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performed under Biosafety level 3 (BSL3) conditions.
Molecular detection of C. burnetii
DNA was extracted from samples and isolates with the
Qiagen Tissue kit (IZASA S.A. Barcelona, Spain). For
arthropods, specimens were first crushed in 1.5 ml
eppendorf tubes with the help of a pestle (Sigma-Aldrich
Química S.A., Barcelona, Spain), as described [21], and
extracted as before. DNA was quantified in a NanoDrop
ND-1000 spectrophotometer (NanoDrop Technologies
Inc. Wilmington, Delaware USA), and about 200 ng were
used for each PCR. Previous to the genotyping, a screening
assay (IS1111-based PCR coupled with hybridization with
a specific probe by reverse line blotting -RLB) was used for
the detection of C. burnetii [22-24].
C. burnetii genotyping
An analysis based on a previous report [15] was performed
to identify which genes/ORFs defined the ascription of
each isolate to a specific GG, and seven of them were
selected (CBU0007, CBU0071, CBU0168, CBU0598,
CBU0881, CBU1805 and CBU2026), whose combination
of presence/absence seems to determine the GG (Table 1).
Also, the detection of adaA (CBU0952) [19] was included
in the method. Primers and probes were designed for their
molecular detection by PCR and subsequent RLB
hybridization (Additional file 2: Table S2) by using Oligo6
software (Molecular Biology Insights, Inc. Cascade, CO,
USA). Incompatibility among primers was avoided by in
silico analysis of the formation of secondary structures,
and oligonucleotides forming dimers with energy values
lower than −6 kcal/mol and hairpins with Tm higher than
40C were discarded. The specificity of the oligonucleotides
was first assessed by blastn (http://www.ncbi.nlm.nih.gov/
blast/Blast.cgi?PAGE=Nucleotides). The reaction mix
included 80 μg/tube of bovine serum albumin (Roche
España, Madrid, Spain), 3.75 mM MgCl2 (Applied Biosys-
tems), 200 μM dNTPs (Applied Biosystems) and 4U of
AmpliTaq GoldW DNA Polymerase (Amersham Pharmacia
Biotech, Cerdanyola del Vallès, Barcelona, Spain). PrimerTable 1 Scheme of the presence/absence of the Coxiella
burnetii ORFs selected for the determination of genomic
groups
Target GGI GGII GGIII GGIV GGV GGVI GGVII GGVIII
CBU0007 + + + − + + + +
CBU 0071 + + + + − + + −
CBU 0168 + + + − + + − +
CBU 0598 + + − + + + + +
CBU 0881 + + + + + − − −
CBU 1805 + + + + − + + +
CBU 2026 + − + + + + + +concentrations ranged from 0.6 to 1 μM (Additional file 2:
Table S2). The amplification cycles included an initial cycle
of 94C for 9 min, followed by 40 cycles of 94C 30 s, 60C
1 min, and 72C 1 min, with a final extension at 72C for
10 min. The amplifications were performed in an MJ
Research PTC-200 (Bio-Rad Laboratories, S.A., Alcobendas,
Madrid, Spain) in volumes of 50 μl. Hybridization by RLB
was performed as described [25] using 48C for the
hybridization and 40C for the conjugate and the washing
steps. Concentration of probes ranged from 0.8 to 6.4
pmols/μl (Additional file 2: Table S2). Two overlapping
films (SuperRX, Fujifilm España S.A., Barcelona, Spain),
were used in each assay to obtain a less and more exposed
image for each membrane.
The sensitivity of the technique was checked with serial
10-fold dilutions of a purified DNA stock of the isolate
Nine Mile phase II (NMII) and the specificity was studied
by subjecting to the method 104 genome equivalents of a
selection of other bacterial species causing zoonoses or
related illness (Orientia tsutsugamushi, Rickettsia conorii,
R. typhi, Legionella pneumophila, Francisella tularensis
subsp. holarctica, Bartonella henselae, Chlamydophila
pneumoniae, and Mycoplasma pneumoniae).
To assess the reproducibility of the methodology, DNA
extracted from 2 different passages (n and n+10) of 5
reference isolates (NMI, CS-27, Priscilla, SQ217, F2) and
a local isolate from cattle (273) (Additional file 1: Table
S1) were analyzed.
The results of the GT study were further analyzed by
using InfoQuest™FP 4.50 (BioRad, Hercules, CA, USA).
Clustering analyses used the binary coefficient (Jaccard)
and UPGMA (Unweigthed Pair Group Method Using
Arithmetic Averages) to infer the phylogenetic
relationships.
Results
Samples included in the study
A total of 90 autochthonous samples were included: 24
from human patients (11 from acute and 13 from
chronic cases) and 66 from animals and ticks (15 from
sheep, 7 from goats, 7 from cattle, 3 from rats, 1 from a
wild boar and 33 from ticks); also, 15 reference strains
were used to validate the method (Additional file 1:
Table S1).
Sensitivity, specificity and reproducibility of the method
The detection limit of the method using purified NMII
DNA was 10 genome equivalents. No reactivity was
detected when testing 104 genome equivalents from 8
other bacterial species causing zoonoses or related illness
(data not shown). To check for reproducibility, passages
“n” (Figure 1, lanes 1–6) and “n+10” (Figure 1, lanes 7–12)
from 5 reference isolates and a local isolate from cattle
were checked without any loss of sensitivity during in vitro
Figure 1 Sensitivity and reproducibility of the method of characterization of Coxiella burnetii. Reproducibility. Lanes 1–6: Isolates NMI, CS-27,
local cattle isolate 273, Priscilla, SQ217 and F2, passage “n”; lanes 7–12: same isolates, passage “n+10”. Results using clinical, veterinary and
arthropod samples. Lane 13: specimen of R. sanguineus (M28CE4GA7C); lanes 14–16: specimens of H. lusitanicum (M28P1GA8A, M28PE14GV5C and
M28PE14GV5F); lane 17: specimen of D. marginatus (M28P2GA45C); lane 18: human serum (2172); lane 19: sheep placenta (70924); lane 20: goat
lung (67025); lane 21: cattle endocervical exudate (70814); lane 22: human clot (BZO18); lane 23: human plasma (0904); lane 24: rat liver (78); lane
25: negative control. Sensitivity. Lanes 26–28: 103, 102 and 10 genome equivalents of isolate NMII. Left panel: position of the probes for each ORF.
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that NMI (phase I) and NMII (phase II) isolates presented
the same results in this characterization; consequently,
only one of them (NMI) was used throughout the study.Genotyping of reference isolates and samples
From the 15 reference isolates that were tested with the
method described here for GG adscription (Table 1), and
from which data from previous studies were available, all
of them fell in the same GG as previously described, the
topology of the tree being consistent with previous data.
None of the reference isolates tested was found to belong
to GG III, VI and VIII (Additional file 1: Table S1,
Figure 2).
Local human samples were found to belong to GG I, IV,
VII and VIII, as follows: 13 samples from chronic cases (7
endocarditis, 3 vascular infections, 1 infected aneurism, 1
osteomyelitis and 1 chronic hepatitis) from 8 different
regions were all infected with GG IV, except for one vascu-
lar infection (GG VIII); acute cases (10 samples of FID with
liver involvement and 1 sample of pneumonia; 4 regions)
showed GG I, IV, VII and VIII (Additional file 1: Table S1,
Table 2, Figures 2 and 3).Among livestock samples, those from sheep (15 samples
from 8 provinces) were found belonging to GG I, II, III, IV
and VIII; goats (7 samples from 4 provinces) were infected
with GG III, IV and VIII; cattle (7 samples from 4 pro-
vinces) were all infected by GG III; rats (3 samples from 1
province) and a wild boar showed GG IV; finally, 33 ticks of
3 species, from 4 areas of 2 adjacent regions, carried always
GG VII, except for one that carried GG VI. In summary,
samples from GG I, II, III, IV, VI, VII and VIII were identi-
fied (Additional file 1: Table S1; Table 2, Figures 2 and 3).adaA detection
Samples from GG I, II and III were always adaA positive;
all GG IV were adaA negative, except for a sheep placenta
that was adaA positive; GG VII samples were adaA nega-
tive, except for a tick specimen; GG VIII samples were posi-
tive, except for a human sample of acute hepatitis; finally,
the only sample available from GG VI (one H. lusitanicum
tick) was adaA negative (Additional file 1: Table S1, Table 2,
Figure 2). All the samples from cases of acute FID with liver
involvement (10 samples from 3 distant regions; Figure 3)
were adaA negative and the only sample available from a
patient with pneumonia was adaA positive.
Figure 2 Dendogram construct from hibridization data of 58 local samples and reference strains. Biological and geographical origin of the
samples is shown. Black boxes indicate presence of the selected ORFs; reference isolates used to validate the method are framed.
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Table 2 Summary of the results of the characterization
GT Human samples Livestock
Acute hepatitis Acute pneumonia Chronic Sheep Goat Cattle Wild animals Ticks Total
I+* 1 1 2
II+ 1 1
III+ 5 3 7 15
IV+ 1 1
IV- 6 12 5 1 4 28
VI- 1 1
VII+ 1 1
VII- 3 31 34
VIII+ 1 2 3 6
VIII- 1 1
Total 10 1 13 15 7 7 4 33 90
*: plus and minus signs refer to adaA presence/absence, respectively.
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GG positive or negative for adaA), 10 were identified in
the samples studied (Table 2).
Discussion
A multiplex PCR coupled with hybridization by RLB for the
characterization of C. burnetii was designed, allowing for its
classification into the previously known 8 GG [15] and into
up to 16 genotypes, depending on adaA presence/absence.
For validation, 15 reference strains characterized in previous
studies were used (Additional file 1: Table S1). All of themFigure 3 Map of Spain showing sampling sites, type of samples and rfell in the same GGs as previously described, when data was
available, or grouped in the same clade as described [8-
10,12,13]. Consequently, an excellent correlation with some
previously published schemes and, specifically, with the
microarray-based whole genome typing of Beare et al. [15]
was observed: the 4 isolates studied by Beare et al. that were
also analyzed in this study (NMI, GG I; Henzerling, GG II;
Priscilla, GG IV; and Scurry Q217, GG V) were classified
with this method into the same GG as described. Also, the
analysis of the results by InfoQuest disclosed a tree whose
topology was similar to that of Beare et al. [15], with theesults.
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gether with GGs I, II and III, instead of with GGs IV, V, VI
and VII as in the Beare study.
With this methodology, a preliminary characterization
of C. burnetii variants circulating in Spain has been per-
formed showing a high variability of this organism in
clinical and environmental settings, identifying 7 GG,
with the exception of GG V, and 10 different GTs.
In Spain, while a respiratory disease is observed in about
80% of cases reported from the Northern region of the
Basque Country [26,27], the Southern regions of Andalusia
and the Canary Islands report a clear predominance (about
90% of cases) of FID with liver involvement [28-34]. This
last has also been described in Australia, France, Greece,
or Taiwan [35-38], among others. Even taking into account
the limited size of this study and the constraint of an ex-
trapolation, a strain-associated factor that might explain
the different clinical presentations of acute Q fever is
hypothesized for our country. The pattern observed in
cases of acute Q fever indicates an association between ab-
sence of adaA and FID with liver involvement, produced
in this study by adaA negative strains in both regions (the
Southern regions of Andalusia and the Canary Islands), al-
though is not statistically significant in this study (p=0.09)
due to low number of samples. Also, another sample of a
case of hepatitis from the north (Basque Country) yielded
an adaA negative result as well. The same applies for the 2
reference isolates from hepatitis cases analyzed in this
study: F2, a French isolate and SQ217, recovered in the
USA from a case of chronic hepatitis, are both adaA nega-
tive as well. In contrast, pneumonia predominates over
liver involvement in Northern Spain, being the only case
of this clinical form available for the study produced by an
adaA positive strain. No other marker used in this study
correlated with the clinical presentation of acute Q fever.
Availability of samples from cases of acute Q fever for
genotyping is much less frequent than from cases of
chronic Q fever, even though acute Q fever is much more
prevalent. In this study, 11 samples from acute cases were
analyzed, although only one was from a case with respira-
tory symptoms, reflecting the limited availability of such
samples, which may be due to a poor clinical awareness.
From the 10 GTs found in the country, only 5 have been
detected in humans and, among them, GT IV- is the most
frequently found in acute and chronic cases (75% of cases).
This GT has also been found in many mammal species
(sheep, goat, wild boar and rats). Whether this could be
interpreted as a higher tendency of this GT to cause illness
in humans can not be inferred by this study, mainly con-
sidering that most of the acute cases (8/11) came from the
same area (Gran Canaria Island). In any case, GT IV- is
highly prevalent also in our chronic cases that came from
8 distant areas of the country, showing a more intensive
circulation of this GT in humans.The association previously proposed between adaA-
negative strains and chronic disease [19] has been repro-
duced here for all chronic cases studied (13 cases), except
for a sample from a vascular infection that was adaA posi-
tive. Beare et al. [15] hypothesized that the association
between GG IV and chronic cases (as in 12 out of 13
chronic cases studied here) could be related to the slow
growth of isolates from this genotype and, therefore, the
induction of a decrease in the immune response. On the
other hand, Zhang et al. hypothesized that adaA positive
strains were related to acute cases [19], as it is the case of
the only sample from a patient with acute pneumonia
available. However, in our study, acute cases of FID with
liver involvement were all produced by adaA negative
strains.
GTs found in humans were also found in sheep, goats,
rats, wild boar and ticks. This distribution of GTs suggests
that sheep and goats are responsible for the transmission
of C. burnetii to humans in Spain, as in other areas [39],
and exhibit a high variability of GT. However, although in
general domestic ruminants are important reservoirs for
C. burnetii and play a relevant role in its transmission to
humans, 4 of 24 human samples were found carrying GTs
not found in ruminants in this work. A recent Spanish
study [40] has also detected C. burnetii in roe deer, wild
boar, carrion birds and hares. Although there is no data
available on the genotyping of these specimens, more
studies are needed to characterize the enzootic cycle of C.
burnetii and its GT distribution in wildlife, as well as to as-
certain whether other sources could be responsible for the
transmission of C. burnetii to humans. GG VII was only
found in ticks (H. lusitanicum, Dermacentor marginatus
and Rhipicephalus sanguineus) and in 3 cases out of 10 of
FID with liver involvement. It is to note that, while
reference isolates from ticks belonged mostly to GG II, this
GG has not been found in ticks in our study. Although the
analyzed tick specimens came from 5 different areas, they
were all from Central Spain, which could be biasing this
data. Transmission of Q fever by tick bite still remains
controversial [41,42], and cases of simultaneous or con-
secutive infections with C. burnetii and other tick-borne
agents have been described [43]. Whether C. burnetii can
be transmitted by tick bite or not, the detection in ticks of
GT VII-, found only in human patients revives this debate.
More studies are needed to definitely clarify this question.
On the other hand, given that GG VII isolates have not
been found in cattle, sheep and goats in this study, we
could think of other unknown reservoirs that could be
involved as a source of infection of this GG for both ticks
and humans. Traditional mammal species on which the
tick species analyzed in this study feed on include rabbits
(frequent all over Spain) for the immature stages of H. lusi-
tanicum, which seems to be very important for the main-
tenance of populations of this tick species, small mammals
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sanguineus. Adult H. lusitanicum and D. marginatus nor-
mally feed on large ungulates. Animals present in the tick
study areas included, apart from cattle, high densities of
rabbits and other wildlife. It is to note that 40 liver samples
from rabbits hunted in Gran Canaria analyzed by PCR
were all negative (data not shown), although more studies
are needed. Whether some of the above mentioned ani-
mals may act as reservoirs for GG VII C. burnetii remains
to be studied.
Interestingly, in 7 cattle samples from 4 distant regions,
only GG III was detected. In the study of Arricau-Bouvery
[13] most of the cattle isolates (12/14) analyzed by MLVA
also grouped together in a clade that is close but different
to the one that include GG I isolates, as in this study. In
Beare’s study GG III is also philogenetically close to GG I
and both clades appear together in the tree. This GG hav-
ing never been found in humans in Spain so far lead us to
hypothesize that cattle could represent a low risk for Q
fever transmission to humans in our country.
One of the added values of the method described here is
that it could be applied to any PCR-positive sample carrying
at least 10 genome equivalents of the target organism, thus
avoiding the need for culturing the organism to obtain data
on the global circulation of C. burnetii. The frequent lack of
human isolates from outbreaks, which are needed to apply
the yet described methods, hamper a correct outbreak study
that are necessary to identify the source of infection. This
methodology allows the characterization directly from
clinical samples avoiding the culture step of this fastidious
bacterium, and proves to be valuable identifying so far 10
different GTs circulating in Spain. This method can be per-
formed in any laboratory with basic equipment. It can easily
determine relationships among C. burnetii from different
origins by using PCR-positive samples, thus helping in the
identification of the source of an outbreak in a rapid
analysis.Conclusions
The method described here is rapid, reproducible and sensi-
tive. It can be applied directly to clinical and environmental
samples, and is able to identify up to 16 GT. This will facili-
tate the acquisition of global data on the circulation of GT
of this organism.
We have found a high variability of C. burnetii in Spain,
with 10 GTs found in different settings, 5 of them in human
samples. Interestingly, all the samples from acute cases of
FID with liver involvement were produced by adaA nega-
tive microorganisms, while the only case of pneumonia
available for the study was caused by a adaA positive strain.
Moreover, the majority (12 cases) of the 13 chronic cases
studied were produced by organisms of GG IV-, except for
a case of vascular infection (GG VIII +).Regarding livestock, human cases share GTs with
sheep and goats, but the only GT found in cattle has
never been found in humans.
The most frequent GT found in ticks (GT VII-; 31 out
of 33 specimens studied) was also found in human sam-
ples of cases of FID with liver involvement. Although the
hypothesis of transmission of Q fever by tick bite still
remains controversial, to further study this point is of
interest.
Additional files
Additional file 1: Table S1. Samples and reference isolates used in the
study.
Additional file 2: Table S2. Oligonucleotides used in the study.
Acknowledgements
We thank Dr. Marco Quevedo, from the Institute of Virology, Bratislava,
Slovakia, and Dra. Fatima Bacelar from the Centro de Estudos de Vectores y
Doenças Infecciosas, Aguas de Moura, Portugal, for their help in setting up
the culture method for C. burnetii, and Aleida Villa, from EXOPOL, Zaragoza,
Spain, for providing local strains from livestock.
We are grateful to COST action B28 C05.0103 “Array technologies for BSL3
and BSL4 pathogens” for providing a platform of cooperation and for the
exchanging of bacterial strains with other European laboratories, specifically
with the Bundeswehr Institute of Microbiology, Munich, Germany (Dr.
Dimitrios Frangoulidis) and the Institute of Virology, Slovak Academy of
Sciences, Bratislava, Slovakia (Dr. Rudolf Toman).
Grant support for this work was from FIS PI10/00165, FUNCIS 26/03 from the
Gobierno de Canarias “Diagnóstico directo de rickettsiosis prevalentes en
nuestro medio (fiebre Q y tifus murino)”, from the “Departamento de
Agricultura y Pesca, Gobierno Vasco” “Ensayo de control de la fiebre Q en la
cabaña ovina lechera de la CAPV”, INIA FAU2006-00002-C04-01 to -04
“Ecología y control de la fiebre Q: Epidemiología molecular de Coxiella
burnetii”, and AGL2010-21273-C03-01-GAN from CICYT “Interacciones-inmuno
endocrinas materno-fetal y con Coxiella burnetii en vacas lecheras de alta
producción”.
Author details
1Laboratorio de Espiroquetas y Patógenos Especiales, Department of
Bacteriology, Centro Nacional de Microbiología, Instituto de Salud Carlos III,
Ctra. de Pozuelo km 2.6, Majadahonda, Madrid 28220, Spain. 2Microbiology
Service and Infectious and Tropical Diseases Unit, Hospital Universitario
Insular de Gran Canaria, Av Marítima del Sur, s/n, 35016 Las Palmas, Spain.
3Department of Production and Animal Health, NEIKER - Instituto Vasco de
Investigación y Desarrollo Agrario, Berreaga Kalea, 1, Derio, Bizkaia 48160,
Spain. 4Department of Animal Health, Facultad de Veterinaria, Universidad
Complutense de Madrid, Avda. Puerta de Hierro, s/n, Madrid 28040, Spain.
5Department of Animal Production, Universidad de Lleida, Pl. de Víctor
Siurana, 1, Lleida 25003, Spain. 6Internal Medicine Service, Hospital Comarcal
de Laredo, Avda. de los Derechos Humanos, s/n, Laredo, Cantabria 39770,
Spain. 7Hospital Universitario Donostia and CIBERES, P° Doctor José
Beguiristain s/n, Donostia-San Sebastián, Guipúzcoa 20014, Spain.
8Department of Animal Medicine and Surgery, Facultad de Veterinaria,
Universidad de Las Palmas de Gran Canaria, Campus Universitario de Arucas
s/n, Arucas, Las Palmas 35413, Spain. 9Present address: Department of
Molecular Genetics and Microbiology, Center for Infectious Diseases, Stony
Brook University, Stony Brook, NY 11794-5120, USA.
Authors’ contributions
IJ, HG, RE and PA participated in the design of the study. CCR, MB, JLPA and
NFR studied clinical and environmental samples from Canary Islands
suspected of C. burnetii infection and provided the positives to the Centro
Nacional de Microbiología-Instituto de Salud Carlos III (CNM-ISCIII) for
molecular analysis. JFB, IA and ALGP studied livestock and tick samples from
the Basque Country and provided the positives to the CNM-ISCIII for
characterization. AT and ASO studied environmental samples from Madrid
Jado et al. BMC Microbiology 2012, 12:91 Page 9 of 10
http://www.biomedcentral.com/1471-2180/12/91and provided the positives to the CNM-ISCIII for characterization. BS and FLG
studied livestock samples from Catalonia and provided the positives to the
CNM-ISCIII for molecular analysis. FPV and GC studied samples from Q fever
patients and provided the positives to the CNM-ISCIII for molecular analysis.
IJ, CGA and MRV participated in the culture and manipulation of the isolates
in the BSL3 laboratory. IJ and PA designed the method of characterization. IJ,
RE, CGA, BL and MRV evaluated and carried out the genotyping method. HG
and PA performed the phylogenetic analysis. IJ, HG, RE and PA participated
in the interpretation of data and drafted the manuscript. All authors have
critically read and approved the final version of the manuscript and also
concur with further revisions of it.
Received: 31 October 2011 Accepted: 1 June 2012
Published: 1 June 2012
References
1. Raoult D, Marrie TJ, Mege JL: Natural history and pathophysiology of Q
fever. Lancet Infect Dis 2005, 5:219–226.
2. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM: Public health
assessment of potential biological terrorism agent. Emerg Infect Dis 2002,
8:225–230.
3. Minnick MF, Heinzen RA, Reschke DK, Frazier ME, Mallavia LP: A plasmid-
encoded surface protein found in chronic-disease isolates of Coxiella
burnetti. Infect Immun 1991, 59:4735–4739.
4. Samuels JE, Frazier ME, Mallavia LP: Correlation of plasmid type and
disease caused by Coxiella burnetii. Infect Immun 1985, 49:775–779.
5. Stein A, Raoult D: Lack of pathotype specific gene in human Coxiella
burnetii isolates. Microb Pathog 1993, 15:177–185.
6. Nguyen SV, Hirai K: Differentiation of Coxiella burnetii isolates by
sequence determination and PCR-restriction fragment length
polymorphism analysis of isocitrate dehydrogenase gene. FEMS Microbiol
Lett 1999, 180:249–254.
7. Andoh M, Nagaoka H, Yamaguchi T, Fukushi H, Hirai K: Comparison of
Japanese isolates of Coxiella burnetii by PCR-RFLP and sequence analysis.
Microbiol Immunol 2004, 2004(48):971–975.
8. Hendrix LR, Samuel JE, Mallavia LP: Differentiation of Coxiella burnetii
isolates by restriction-endonuclease-digested DNA separated by
SDS-PAGE. J Gen Microbiol 1991, 137:269–276.
9. Jager C, Willems H, Thiele D, Baljer G: Molecular characterization of Coxiella
burnetii isolates. Epidemiol Infect 1998, 120:157–164.
10. Glazunova O, Roux V, Freylikman O, Sekeyova Z, Fournous G, Tyczka J,
Tokarevich N, Kovacava E, Marrie TJ, Raoult D: Coxiella burnetii genotyping.
Emerg Infect Dis 2005, 11:1211–1217.
11. Mediannikov O, Fenollar F, Socolovschi C, Diatta G, Bassene H, Molez JF,
Sokhna C, Trape JF, Raoult D: Coxiella burnetii in humans and ticks in rural
Senegal. PLoS Negl Trop Dis 2010, 4:e654.
12. Svraka S, Toman R, Skultety L, Slaba K, Homan WL: Establishment of a
genotyping scheme for Coxiella burnetii. FEMS Microbiol Lett 2006,
254:268–274.
13. Arricau-Bouvery N, Hauck Y, Bejaoui A, Frangoulidis D, Bodier CC, Souriau A,
Meyer H, Neubauer H, Rodolakis A, Vergnaud G: Molecular characterization
of Coxiella burnetii isolates by infrequent restriction site-PCR and MLVA
typing. BMC Microbiol 2006, 6:38.
14. Roest HI, Ruuls RC, Tilburg JJ, Nabuurs-Franssen MH, Klaassen CH, Vellema P,
van den Brom R, Dercksen D, Wouda W, Spierenburg MA, van der Spek AN,
Buijs R, de Boer AG, Willemsen PT, van Zijderveld FG: Molecular
epidemiology of Coxiella burnetii from ruminants in Q fever outbreak,
the Netherlands. Emerg Infect Dis 2011, 17:668–675.
15. Beare PA, Samuel JE, Howe D, Virtaneva K, Porcella SF, Heinzen RA: Genetic
diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-
based whole-genome comparisons. J Bacteriol 2006, 188:2309–2324.
16. Denison AM, Thompson HA, Massung RF: IS1111 insertion sequences of
Coxiella burnetii: characterization and use for repetitive element
PCR-based differentiation of Coxiella burnetii isolates. BMC Microbiol 2007,
7:91.
17. Huijsmans CJ, Schellekens JJ, Wever PC, Toman R, Savelkoul PH, Janse I,
Hermans MH: Single-nucleotide-polymorphism genotyping of Coxiella
burnetii during a Q fever outbreak in The Netherlands. Appl Environ
Microbiol 2011, 77:2051–2057.
18. Hornstra HM, Priestley RA, Georgia SM, Kachur S, Birdsell DN, Hilsabeck R,
Gates LT, Samuel JE, Heinzen RA, Kersh GJ, Keim P, Massung RF, Pearson T:
Rapid typing of Coxiella burnetii. PLoS One 2011, 6:e26201.19. Zhang G, To H, Russell KE, Hendrix LR, Yamaguchi T, Fukushi H, Hirai K,
Samuel JE: Identification and characterization of an immunodominant
28-kilodalton Coxiella burnetii outer membrane protein specific to
isolates associated with acute disease. Infect Immun 2005, 73:1561–1567.
20. Musso D, Raoult D: Coxiella burnetii blood cultures from acute and
chronic Q-fever patients. J Clin Microbiol 1995, 33:3129–3132.
21. Toledo A, Olmeda AS, Escudero R, Jado I, Valcárcel F, Casado-Nistal MA,
Rodríguez-Vargas M, Gil H, Anda P: Tick-borne zoonotic bacteria in ticks
collected from central Spain. AmJTrop Med Hyg 2009, 81:67–74.
22. Willems H, Thiele D, Frolich-Ritter R, Krauss H: Detection of Coxiella burnetii
in cow’s milk using the polymerase chain reaction (PCR). Zentralbl Vet B
1994, 41:580–587.
23. Berri M, Laroucau K, Rodolakis A: The detection of Coxiella burnetii from
ovine genital swabs, milk and fecal samples by the use of a single
touchdown polymerase chain reaction. Vet Microbiol 2000, 72:285–293.
24. Barandika JF, Hurtado A, García-Esteban C, Gil H, Escudero R, Barral M, Jado I,
Juste RA, Anda P, García-Pérez AL: Tick-borne zoonotic bacteria in wild
and domestic small mammals in northern Spain. Appl Environ Microbiol
2007, 73:6166–6171.
25. Jado I, Escudero R, Gil H, Jiménez-Alonso MI, Sousa R, García-Pérez AL,
Rodríguez-Vargas M, Lobo B, Anda P: Molecular method for identification
of Rickettsia species in clinical and environmental samples. J Clin Microbiol
2006, 44:4572–4576.
26. Montejo-Baranda M, Corral-Carranceja J, Aguirre-Errasti C: Q fever in the
Basque Country: 1981–1984. Rev Infect Dis 1985, 7:700–701.
27. Montes M, Cilla G, Vicente D, Nieto V, Ercibengoa M, Perez-Trallero E:
Gipuzkoa, Basque Country, Spain (1984–2004): a hyperendemic area of Q
fever. Ann N Y Acad Sci 2006, 1078:129–132.
28. Alarcón A, Villanueva JL, Viciana P, López-Cortés L, Torronteras R, Bernabeu
M, Cordero E, Pachón J: Q fever: epidemiology, clinical features and
prognosis. A study from 1983 to 1999 in the South of Spain. J Infect 2003,
47:110–116.
29. Bolaños M, Santana OE, Pérez-Arellano JL, Ángel-Moreno A, Moreno G,
Burgazzoli JL, Martín-Sánchez AM: Fiebre Q en Gran Canaria: 40 nuevos
casos. Enferm Infecc Microbiol Clin 2003, 21:20–23.
30. Lepe JA, Guerrero FJ, Ruiz-Calderón A, del Castillo E, Gómez-Salvago S,
Jiménez-Alonso MA, Palomo S, Perea R: Epidemiología de la fiebre Q en la
zona norte de Huelva. Enferm Infecc Microbiol Clin 1999, 17:65–68.
31. Pascual-Velasco F, Borobio MV, González Z, Carrascosa M: Clinical
presentation of acute Q fever in Lanzarote (Canary Islands): a 2-year
prospective study. Scand J Infect Dis 1996, 28:533–534.
32. Rivero A, Zambrana JL, Pachón J: Fiebre de duración intermedia. Enferm
Infecc Microbiol Clin 2003, 21:147–152.
33. Romero-Jiménez MJ, Suárez-Lozano I, Fajardo JM, Benavente A, Menchero A,
de la Iglesia A: Hepatitis como manifestación única de la fiebre Q:
características clínicas y epidemiológicas en 109 pacientes. Enferm Infecc
Microbiol Clin 2003, 21:193–195.
34. Millán Mon A, Argany Fajardo A, Febles Bethencourt J, González Caloca C,
Vento Remedios TE, Fernández Cabrera M: Fiebre Q en la isla de La Palma.
Revisión de 35 pacientes. An Med Interna 1989, 6:527–530.
35. Derrick E: The course of infection with Coxiella burnetii. Med J Aust 1973,
1:1051–1057.
36. Tissot Dupont H, Raoult D, Brouqui P, Janbon F, Peyramond D, Weiller PJ,
Chicheportiche C, Nezri M, Poirier R: Epidemiologic features and clinical
presentation of acute Q fever in hospitalized patients: 323 French cases.
Am J Med 1992, 93:427–434.
37. Gikas A, Kofteridis DP, Manios A, Pediaditis J, Tselentis Y: Newer macrolides
as empiric treatment for acute Q fever infection. Antimicrob Agents
Chemother 2001, 45:3644–3646.
38. Chang K, Yan JJ, Lee HC, Liu KH, Lee NY, Ko WC: Acute hepatitis with or
without jaundice: a predominant presentation of acute Q fever in
southern Taiwan. J Microbiol Immunol Infect 2004, 37:103–108.
39. Tissot-Dupont H, Amadei MA, Nezri M, Raoult D: Wind in November, Q
fever in December. Emerg Infect Dis 2004, 10:1264–1269.
40. Astobiza I, Barral M, Ruiz-Fons F, Barandika JF, Gerrikagoitia X, Hurtado A,
García-Pérez AL: Molecular investigation of the occurrence of Coxiella
burnetii in wildlife and ticks in an endemic area. Vet Microbiol 2011,
147:190–194.
41. Cinco M, Luzzati R, Mascioli M, Floris R, Brouqui P: Serological evidence of
Rickettsia infections in forestry rangers in north-eastern Italy. Clin
Microbiol Infect 2006, 12:493–495.
Jado et al. BMC Microbiology 2012, 12:91 Page 10 of 10
http://www.biomedcentral.com/1471-2180/12/9142. Pascual-Velasco F, Carrascosa-Porras M, Martínez-Bernal MA, Jado-García I:
Fiebre Q tras picadura de garrapata. Enferm Infecc Microbiol Clin 2007,
25:360.
43. Rolain JM, Gouriet F, Brouqui P, Larrey D, Janbon F, Vene S, Jarnestrom V,
Raoult D: Concomitant or consecutive infection with Coxiella burnetii and
tickborne diseases. Clin Infect Dis 2005, 40:82–88.
doi:10.1186/1471-2180-12-91
Cite this article as: Jado et al.: Molecular method for the characterization
of Coxiella burnetii from clinical and environmental samples: variability
of genotypes in Spain. BMC Microbiology 2012 12:91.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
